How a Growing Biopharma Can Scale Clinical Trials with eTMF
In this interview, we speak with Carolyn Jin, Director of Clinical Systems and Document Management at Kura Oncology. She...
Moe Alsumidaie
Transforming Diabetes Treatment: Insights from Sernova Leadership
In this interview, I spoke with Jonathan Rigby, CEO of Sernova, and Francis Shannon, SVP of Clinical Development and...
Addressing the Accuracy Crisis in Clinical Trial Imaging
A recent panel podcast on The Imaging Accuracy Crisis in Clinical Trials brought to light critical issues and innovative...
Embracing Technology in Clinical Operations: A Conversation with Bonne Adams of Inhibrx
We had the pleasure of speaking with Bonne Adams, Vice President of Operations at Inhibrx Therapeutics, at the Veeva...
How Causal Machine Learning is Transforming Clinical Trials
Welcome to an insightful discussion on the future of clinical trials and the role of causal machine learning in...
Unpacking New FDA Guidance: Processes and Practices for BIMO Inspections
The U.S. FDA issued a draft guidance document, “Processes and Practices Applicable to Bioresearch Monitoring (BIMO) Inspections,” to streamline...
OHRP’s 7th Exploratory Workshop: Navigating AI in Clinical Trials
The Office for Human Research Protections (OHRP) recently hosted its 7th exploratory workshop, focusing on the increasingly pervasive topic...
Diversity in Clinical Trials: How the FDA’s Guidelines Miss the Mark on Inclusion
Today, we had the privilege of sitting with Mumbi Kairu from The Pamoja Research Institute in Anaheim, California. Mumbi...
Where Parexel Stands on The Future of Clinical Trials
At the 2024 DPHARM Conference, we had the chance to interview Peyton Howell, CEO of Parexel, and she shared...
Why Innovation in Big Pharma Is So Slow: Insights from BMS
At the 2023 DPHARM conference, Hassan Kadhim from Bristol-Myers Squibb offered an insightful look into the challenges driving innovation...